Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial-Reference-Cited by-同舟云学术

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial

Published:2015-12 Issue:10012 Volume:386 Page:2507-2519
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Desai Meghna,Gutman Julie,L'lanziva Anne,Otieno Kephas,Juma Elizabeth,Kariuki Simon,Ouma Peter,Were Vincent,Laserson Kayla,Katana Abraham,Williamson John,ter Kuile Feiko O

Funder

The Malaria in Pregnancy Consortium

Bill & Melinda Gates Foundation

Malaria in Pregnancy Consortium

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study;Dellicour;PLoS Med,2010

2. Epidemiology and burden of malaria in pregnancy;Desai;Lancet Infect Dis,2007

3. Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study;Walker;Lancet Glob Health,2014